DKDRF (NewMed Energy LP) Cyclically Adjusted Revenue per Share: $0.67 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DKDRF NewMed Energy LP DKDRF
70 GF Score
Price $5.10
GF Value $2.88
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is NewMed Energy LP Cyclically Adjusted Revenue per Share?

NewMed Energy LP DKDRF 70 Cyclically Adjusted Revenue per Share is $0.67 as of Mar. 2026. GuruFocus rates DKDRF with a GF Score™ of 70/100 and a GF Value™ of $2.88 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

NewMed Energy LP's adjusted revenue per share for the three months ended in Mar. 2026 was $0.140. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.67 for the trailing ten years ended in Mar. 2026.

During the past 12 months, NewMed Energy LP's average Cyclically Adjusted Revenue Growth Rate was -3.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 5.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of NewMed Energy LP was 14.90% per year. The lowest was 5.50% per year. And the median was 12.75% per year.

As of today (2026-07-20), NewMed Energy LP's current stock price is $5.10. NewMed Energy LP's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $0.67. NewMed Energy LP's Cyclically Adjusted PS Ratio of today is 7.61.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of NewMed Energy LP was 10.40. The lowest was 1.77. And the median was 4.98.


NewMed Energy LP  (OTCPK:DKDRF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

NewMed Energy LP's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=5.10/0.67
=7.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of NewMed Energy LP was 10.40. The lowest was 1.77. And the median was 4.98.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


NewMed Energy LP Cyclically Adjusted Revenue per Share Related Terms


NewMed Energy LP Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for NewMed Energy LP's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NewMed Energy LP Cyclically Adjusted Revenue per Share Chart

NewMed Energy LP Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.52 0.53 0.54 0.65 0.71

NewMed Energy LP Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.64 0.68 0.65 0.71 0.67

DKDRF vs COP, EOG, FANG: Cyclically Adjusted Revenue per Share Comparison

For the Oil & Gas E&P subindustry, NewMed Energy LP's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NewMed Energy LP Cyclically Adjusted PS Ratio vs Oil & Gas Industry

For the Oil & Gas industry and Energy sector, NewMed Energy LP's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where NewMed Energy LP's Cyclically Adjusted PS Ratio falls into.


DKDRF
70GF Score
NewMed Energy LP DKDRF
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NewMed Energy LP Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, NewMed Energy LP's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.14/330.2130*330.2130
=0.140

Current CPI (Mar. 2026) = 330.2130.

NewMed Energy LP Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.111 241.018 0.152
201609 0.127 241.428 0.174
201612 0.117 241.432 0.160
201703 0.124 243.801 0.168
201706 0.125 244.955 0.169
201709 0.093 246.819 0.124
201712 0.086 246.524 0.115
201803 0.091 249.554 0.120
201806 0.097 251.989 0.127
201809 0.106 252.439 0.139
201812 0.097 251.233 0.127
201903 0.100 254.202 0.130
201906 0.087 256.143 0.112
201909 0.102 256.759 0.131
201912 -0.286 256.974 -0.368
202003 0.121 258.115 0.155
202006 0.097 257.797 0.124
202009 0.154 260.280 0.195
202012 0.128 260.474 0.162
202103 0.184 264.877 0.229
202106 0.189 271.696 0.230
202109 0.207 274.310 0.249
202112 0.171 278.802 0.203
202203 0.210 287.504 0.241
202206 0.248 296.311 0.276
202209 0.271 296.808 0.302
202212 0.246 296.797 0.274
202303 0.239 301.836 0.261
202306 0.214 305.109 0.232
202309 0.243 307.789 0.261
202312 0.236 306.746 0.254
202403 0.224 312.332 0.237
202406 0.252 314.175 0.265
202409 0.267 315.301 0.280
202412 0.225 315.605 0.235
202503 0.245 319.799 0.253
202506 0.163 322.561 0.167
202509 0.238 324.800 0.242
202512 0.215 324.054 0.219
202603 0.140 330.213 0.140

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $0.67 mean?
NewMed Energy LP (DKDRF) has a Cyclically Adjusted Revenue per Share of $0.67 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on NewMed Energy LP and its competitors.
Is NewMed Energy LP's Cyclically Adjusted Revenue per Share too high?
NewMed Energy LP's current Cyclically Adjusted Revenue per Share is $0.67. Overall, NewMed Energy LP has a GF Score™ of 70/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NewMed Energy LP's Cyclically Adjusted Revenue per Share compare to COP and EOG?
NewMed Energy LP's Cyclically Adjusted Revenue per Share of $0.67 can be compared against companies in the Oil & Gas industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for an Oil & Gas company?
A good Cyclically Adjusted Revenue per Share depends on the Oil & Gas industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on NewMed Energy LP and its competitors. NewMed Energy LP's current Cyclically Adjusted Revenue per Share is $0.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NewMed Energy LP stock overvalued right now?
Based on GuruFocus' analysis, NewMed Energy LP (DKDRF) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.88, compared to a current price of $5.10 — trading 77.1% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $0.67. NewMed Energy LP's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For NewMed Energy LP (DKDRF), the current Cyclically Adjusted Revenue per Share is $0.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NewMed Energy LP (DKDRF) Overvalued in 2026?

Based on GuruFocus' analysis, NewMed Energy LP stock appears to be overvalued. The current stock price of $5.10 is trading 77.1% above its estimated GF Value™ of $2.88. GuruFocus considers NewMed Energy LP to be Significantly Overvalued.

Key valuation signals for DKDRF:

  • Cyclically Adjusted Revenue per Share: $0.67
  • GF Value™: $2.88 vs. price of $5.10 (77.1% above fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the DKDRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


NewMed Energy LP Business Description

Industry EnergyOil & Gas
Other Exchanges NWMD:Israel
Address 19 Abba Even Boulevard, Hertzliya Pituach, Hertzliya, ISR, 4672537
NewMed Energy LP operates in the energy field. Its primary business is exploring, developing, producing, and marketing natural gas, condensate, and oil in Israel and Cyprus and promoting various natural gas-based projects. The Partnership aims to increase the volume of its natural gas sales.
70GF Score

Get the complete analysis for DKDRF

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.10
Price
$2.88
GF Value